ECMO in Poisoning-Related Heart Failure: When the Heart Needs a Machine to Survive

Toxic poisoning can collapse the heart within hours. Extracorporeal Membrane Oxygenation (ECMO) is now a proven bridge that keeps patients alive long enough for the poison to clear — here is what every family and clinician in Jaipur should know.

By the Critical Care & ECMO Team, Apex Hospitals Malviya Nagar · Published July 2025

Why Poisoning Can Stop the Heart

Acute poisoning is one of medicine's most time-critical emergencies. Certain toxins — organophosphates, tricyclic antidepressants, calcium-channel blockers, beta-blockers, digoxin, and industrial chemicals — do not merely cause nausea or sedation. They directly attack the heart's electrical conduction system and myocardial contractility, triggering a cascade that can lead to refractory cardiogenic shock within minutes to hours of ingestion.

In these cases, conventional resuscitation — intravenous fluids, vasopressors, antidotes — is often insufficient. The heart is too suppressed to respond, and every minute of inadequate perfusion causes irreversible organ damage. This is precisely where Extracorporeal Membrane Oxygenation (ECMO) has emerged as a life-saving intervention.

According to the World Health Organization, poisoning accounts for hundreds of thousands of deaths globally each year, with a significant proportion attributable to cardiovascular collapse. Recognising the cardiac dimension of toxic emergencies is the first step toward saving these patients.

What Is ECMO and How Does It Work?

ECMO is an advanced form of extracorporeal life support that temporarily takes over the function of the heart, the lungs, or both. Blood is drawn from the patient through a large cannula, passed through an oxygenator membrane that adds oxygen and removes carbon dioxide, and then returned to the circulation — all outside the body.

There are two principal configurations relevant to poisoning emergencies:

Veno-Arterial (VA) ECMO: Blood is drawn from a vein and returned to an artery, bypassing both the heart and lungs. This is the configuration used in poisoning-related cardiogenic shock, as it directly unloads the failing heart and maintains systemic perfusion.
Veno-Venous (VV) ECMO: Supports lung function only; used when respiratory failure is the dominant problem without significant cardiac compromise.

In toxic cardiogenic shock, VA-ECMO acts as a mechanical bridge — it sustains the patient's circulation while the body metabolises and eliminates the offending toxin. Once the poison clears and the myocardium recovers, ECMO is gradually weaned and removed.

VA-ECMO circuit diagram for poisoning-induced cardiac failure

Which Poisons Most Commonly Cause Cardiac Failure?

Not every poisoning requires ECMO, but certain toxins carry a disproportionate risk of cardiac collapse. Clinicians at Apex Hospitals' ICU and Critical Care unit are trained to identify these high-risk presentations early:

Organophosphate compounds — widely used in agricultural Rajasthan; cause cholinergic crisis with bradycardia, bronchospasm, and myocardial depression.
Calcium-channel blockers (CCBs) — overdose causes profound bradycardia and vasodilation; one of the most lethal pharmaceutical overdoses known.
Beta-blockers — suppress cardiac output and heart rate; resistant to standard antidotes in severe overdose.
Tricyclic antidepressants (TCAs) — cause sodium-channel blockade leading to wide-complex arrhythmias and sudden cardiac arrest.
Digoxin — narrow therapeutic window; toxicity causes life-threatening bradyarrhythmias and ventricular fibrillation.
Aconitine (from herbal preparations) — increasingly reported in India; causes rapid-onset ventricular arrhythmias.
Industrial chemicals and heavy metals — arsenic, thallium, and certain solvents can cause acute cardiomyopathy.

In Rajasthan, organophosphate poisoning from agricultural exposure remains a significant public health concern, making familiarity with ECMO-assisted management particularly relevant for regional critical care teams.

When Is ECMO Indicated in Toxic Cardiac Failure?

The decision to initiate ECMO in a poisoned patient is not taken lightly. It requires a multidisciplinary team — intensivists, cardiologists, and perfusionists — working in concert. Broadly accepted clinical triggers include:

Refractory cardiogenic shock despite high-dose vasopressors and inotropes
Cardiac arrest that does not respond to standard Advanced Cardiac Life Support (ACLS) within a reasonable window
Severe bradycardia or arrhythmia unresponsive to antidotes (e.g., atropine, glucagon, high-dose insulin)
Rapidly deteriorating haemodynamics with a known reversible toxin on board
Anticipated prolonged toxin elimination time (e.g., fat-soluble drugs with long half-lives)

A critical concept here is reversibility. ECMO is most justified when the underlying cause of cardiac failure is expected to resolve — and poisoning, by definition, is a reversible insult once the toxin is cleared. This makes toxic cardiogenic shock one of the strongest indications for ECMO support, with outcomes that can be dramatically better than in structural heart disease.

A 2023 analysis published in PubMed-indexed critical care literature has highlighted that early ECMO initiation — before prolonged low-flow states cause multi-organ damage — is the single most important determinant of survival in poisoning-induced cardiac arrest.

The ECMO Journey: What Happens Step by Step

Understanding the clinical pathway helps families and referring physicians set realistic expectations:

Rapid assessment and toxin identification: Emergency toxicology screen, ECG, echocardiography, and haemodynamic monitoring are initiated simultaneously in the Emergency and Trauma unit.
Antidote and supportive therapy: Specific antidotes (e.g., atropine for organophosphates, glucagon and high-dose insulin for CCB/beta-blocker overdose, digoxin-specific antibody fragments) are administered without delay.
ECMO cannulation: If haemodynamics continue to deteriorate, the ECMO team performs percutaneous cannulation — typically femoral vein and femoral artery — under ultrasound guidance. The procedure takes 15–30 minutes in experienced hands.
Stabilisation on ECMO: Once on circuit, the patient's blood pressure, oxygen delivery, and organ perfusion are restored. The heart is effectively resting while the toxin is metabolised.
Monitoring and weaning: Serial echocardiograms and haemodynamic assessments guide the weaning process. As cardiac function recovers, ECMO flow is gradually reduced.
Decannulation and recovery: Once the patient demonstrates adequate native cardiac output, cannulas are removed. Intensive rehabilitation and organ-function monitoring continue in the physiotherapy and rehabilitation phase.

Outcomes: What Does the Evidence Say?

Survival rates for ECMO in poisoning-related cardiac failure are considerably more encouraging than for other causes of refractory cardiogenic shock. Published case series and registry data report survival-to-discharge rates ranging from 50% to over 80% in well-selected poisoning patients — a stark contrast to the near-universal mortality of untreated refractory toxic cardiac arrest.

At Apex Hospitals, our ECMO programme has achieved an 80% survival rate across ECMO cases — one of the strongest outcomes documented in Rajasthan. This reflects not only the technology but the multidisciplinary expertise of our intensivists, cardiac surgeons, and perfusionists working as a coordinated team around the clock.

Key factors that improve outcomes include: early ECMO initiation before prolonged cardiac arrest, a known and reversible toxin, absence of pre-existing severe cardiac disease, and access to a high-volume ECMO centre with 24×7 cannulation capability.

ECMO for Cardiac Failure at Apex Hospitals, Jaipur

Advanced ECMO infrastructure: Both Veno-Venous and Veno-Arterial ECMO machines are available at our Malviya Nagar facility, with a dedicated ECMO team on call 24×7.
80% ECMO survival rate — among the best documented outcomes in Rajasthan, reflecting the depth of our critical care expertise.
HOPE Tele-ICU Command Centre: Our 24×7 remote ICU monitoring platform connects 18 partner sites across Rajasthan, enabling early identification of deteriorating poisoning patients and timely transfer to our ECMO-capable centre before the window for intervention closes.
NABH-accredited critical care: All ECMO procedures are conducted within our NABH-accredited Cardiac ICU and Advanced ICU with continuous haemodynamic monitoring and on-site emergency labs.
Integrated toxicology and cardiology support: Our cardiology team in Jaipur works alongside intensivists and emergency physicians to ensure seamless decision-making from the moment a poisoning patient arrives.
Featured in Harvard Business Review for the HOPE Tele-ICU Programme — a recognition of our commitment to extending critical care beyond hospital walls.

Recognising the Warning Signs: When to Seek Emergency Care

For families and bystanders, speed is everything. If someone has ingested a potentially toxic substance and develops any of the following, call emergency services and head to the nearest ECMO-capable hospital immediately:

Loss of consciousness or unresponsiveness
Irregular, very slow, or absent pulse
Severe difficulty breathing or blue discolouration of lips and fingertips
Seizures following known or suspected ingestion
Profuse sweating, pinpoint pupils, and excessive secretions (classic organophosphate signs)
Collapse or cardiac arrest

Our Emergency and Trauma unit at Apex Hospitals Jaipur is equipped with Emergency OTs available 24×7 and on-site CT, MRI, and emergency labs to manage poisoning emergencies from the moment of arrival.

Beyond the Heart: Protecting Other Organs During Toxic Shock

Poisoning-related cardiac failure rarely affects the heart in isolation. The kidneys, liver, and brain are simultaneously at risk from reduced perfusion. ECMO's ability to restore systemic blood flow rapidly is therefore protective for multiple organ systems at once.

Acute kidney injury is a common complication of toxic cardiogenic shock. Apex Hospitals' integrated approach includes CRRT (Continuous Renal Replacement Therapy) machines alongside ECMO for patients who develop renal failure — a combination that addresses both the cardiac and renal dimensions of severe poisoning simultaneously. Our nephrology team in Jaipur is closely involved in the management of these complex cases.

Neurological outcomes are similarly improved when ECMO restores cerebral perfusion quickly. Our neurology specialists monitor for hypoxic-ischaemic injury and guide rehabilitation planning once the acute phase has passed.

Frequently Asked Questions

Can ECMO be used for all types of poisoning?

No. ECMO is specifically indicated when poisoning causes refractory cardiogenic shock or cardiac arrest that does not respond to standard resuscitation and antidotes. The toxin must be expected to clear from the body — making poisoning one of the best indications for ECMO because it is inherently reversible. Patient selection is critical and is made by a multidisciplinary team.

How quickly does ECMO need to be started in poisoning emergencies?

Speed is paramount. The best outcomes are seen when ECMO is initiated before prolonged low-flow states cause irreversible multi-organ damage. In practice, this means the decision to cannulate should be made within minutes of recognising refractory haemodynamic failure — not after exhausting every other option over hours.

Is ECMO painful? What does the patient experience?

Patients requiring ECMO for cardiac failure are typically sedated and on mechanical ventilation, so they are not conscious during cannulation or the initial ECMO run. As they stabilise and are weaned from sedation, they may be aware of the cannulas and monitoring equipment. The clinical team manages comfort carefully throughout.

What are the risks of ECMO?

ECMO carries real risks including bleeding (because anticoagulation is required to prevent clotting in the circuit), infection, limb ischaemia at the cannulation site, and stroke. These risks are carefully managed by experienced ECMO teams and are weighed against the near-certain mortality of untreated refractory toxic cardiac failure.

How long does a patient stay on ECMO for poisoning?

Duration depends on the toxin's elimination half-life and the speed of myocardial recovery. For many pharmaceutical overdoses, ECMO support of 24–72 hours is sufficient for the heart to recover once the drug is metabolised. Some cases with slower-clearing toxins or additional complications may require longer support.

Does Apex Hospitals in Jaipur offer ECMO for poisoning emergencies?

Yes. Apex Hospitals Malviya Nagar, Jaipur, operates a 24×7 ECMO programme with both VA and VV ECMO capability, a dedicated perfusion team, and a Cardiac ICU. Our HOPE Tele-ICU network also enables early identification and coordinated transfer of critically ill poisoning patients from across Rajasthan.

References

Concerned About a Poisoning Emergency in Jaipur?

Apex Hospitals' 24×7 ECMO and Critical Care team is ready to respond — if you have a patient in toxic cardiac failure, every minute matters.

Learn About Our ECMO Programme